Iraq Pakistan Morocco authorized emergency use of China COVID-19 vaccine

Iraq Pakistan Morocco authorized emergency use of China COVID-19 vaccine.  Iraq, Pakistan, and Morocco authorized the emergency use of Sinopharm’s China Bio- COVID-19 vaccine.

Approved for emergency use in Iraq

According to Iraqi media reports on the 19th, the Iraqi National Drug Administration has approved the COVID-19 vaccine produced by Sinopharm Sinopharm for emergency use.

Iraqi Ministry of Health spokesperson Saif Badr told Xinhua News Agency that the Chinese vaccine meets the scientific standards set by the Iraqi National Drug Screening Agency, so Iraq approved the emergency use of the COVID-19 vaccine produced by Chinese organisms in Iraq.

According to a report from the Iraqi Ministry of Health on the 19th, 823 new cases were confirmed in Iraq on that day, and a total of 609,852 confirmed cases; 9 new deaths and a total of 12,962 deaths; a total of 573,011 cases were cured.

Approved for emergency use in Pakistan

Xinhua News Agency, Islamabad, January 20. The Pakistan Drug Administration recently granted emergency use authorization to China’s bio- COVID-19 inactivated vaccine. This is the second COVID-19 vaccine approved for emergency use in Pakistan.

According to the announcement on the official website of the Pakistani Drug Administration, the agency approved the emergency use authorization of China’s new biological COVID-19 inactivated vaccine at the registration committee meeting held on the 18th.

According to the official website of the Ministry of Health of Pakistan, as of 8 o’clock on the 20th local time, the country had a total of 524,783 confirmed cases of new coronavirus disease, a total of 11,103 deaths, and a total of 478,517 cured cases.

Approved for emergency use in Morocco

Xinhua News Agency, Rabat, January 23. The Moroccan Ministry of Health issued a communiqu on the 22nd stating that Morocco has formally approved the emergency use of the Chinese bio- COVID-19 inactivated vaccine in Morocco.

The communiqué stated that the National Authorization Committee under the Ministry of Health of Morocco made the above decision after careful evaluation of China’s bio- COVID-19 vaccine. The authorization is valid for 12 months.

The Ministry of Health of Morocco issued an announcement on the 22nd stating that national vaccination will be officially launched next week, with priority given to people who are susceptible to the new coronavirus that meet the requirements.

The Moroccan Ministry of Health reported 950 new confirmed cases on the 23rd, with a total of 465,769 confirmed cases, of which 441,693 were cured and 8,128 died.

China Biotech (SINOPHARM) has gone all out to accelerate the phase III clinical research of the COVID-19 inactivated vaccine, and promote the registration and marketing and emergency use of foreign countries. .

Since June, Phase III clinical studies have been carried out in the UAE, Bahrain, Egypt, Jordan, Peru, Argentina, Morocco and other countries. It is the world’s most invested and fastest-growing clinical research on the COVID-19 vaccine. Up to now, more than 60,000 volunteers have been enrolled in the vaccination group, covering 125 nationalities. It has been approved for emergency use in 9 countries other than China, and has been approved for registration in 2 countries.

(source:internet, reference only)

Disclaimer of medicaltrend.org